[1] 王阳,李伟鹏,李政.芳香化酶抑制剂治疗男性不育症的研究进展 [J].中华泌尿外科杂志,2019,40(10):798-800. [2] 冯强,马志伟,王寓.男性不育症患者生殖支原体感染与精液常规参数及精子DNA完整性的相关性 [J].中华男科学杂志,2020,26(10):900-905. [3] 马媛,海溧,陈书强.男方畸形精子症对胚胎植入前遗传学筛查患者胚胎非整倍体及胚胎发育指标的影响 [J].中国妇产科临床杂志,2018,24 (8):705-707. [4] 李定明,刘博,鲜泱.不同浓度稀少精子冷冻技术效果的观察 [J].中华男科学杂志, 2018,24(5):447-451. [5] 陈振文.辅助生殖男性技术 [M].北京:人民卫生出版社,2016. [6] CAVALLINI G, BERETTA G, BIAGIOTTI G.Preliminary study of letrozole use for improving spermatogenesis in non-obstructive azoospermia patients with normal serum FSH[J]. Asian J Androl,2011,13(6):895-857. [7] PISARSKA M D,CHAN J L,LAWRENSON K,et al.Genetics and epigenetics of infertility and treatments on outcomes[J].J Clin Endocrinol Metab,2019,104(6):1871-1886. [8] 侯建文,孟祥黔.单精子冷冻研究进展[J].中华男科学杂志,2018,24(5):447-451. [9] 白双勇,王剑松,赵庆华.重组人生长激素联合来曲唑治疗肥胖男性少弱精子症疗效分析[J].中华男科学杂志,2015,21(3):280-282. [10] 李宏军.芳香化酶抑制剂在男性不育治疗中的应用[J].生殖医学杂志,2015,24(7):597-600. [11] PATRY G, JARVI K, GROBER E D,et al. Use of the aromatase inhibitor letrozole to treat male infertility[J]. Fertil Steril,2009,92(2):829. E1-2. [12] CAVALLINI G,BIAGIOTTI G,BOLZON E. Multivariate analysi s to predict letrozol eefficacy in improving sperm count of nonobst ructive azoospermic and cryptozoospermic patients:a pilot study[J]. Asian J Androl,2013,15(6):806-811. [13] 欧阳海,谭艳,谢胜,等. 来曲唑在非梗阻性无精子症中应用效果研究[J].生殖医学杂志,2017,26(10):989-994. [14] 蒲江波,李雪梅,朱文杰,等. 绒促性素联合小剂量雄激素治疗少精子及弱精子症效果观查[J].山东医学,20116,56(30):89-91. [15] MILLER G D,MOORE C,NAIR V,et al. Hypothalamic pituitary testicular axiseffects and urinarydetection following clomiphene administrztion in males[J].J Clin Endocrinol Metab,2019,104(3):906-914. [16] 田芙颖,刁瑞英,镇万华,等. 来曲唑治疗男性少弱精子症的临床研究[J].中国计划生育学杂志,2016,24(9):606-609. [17] 王宇宁,魏文杨,宋焱鑫,等. 来曲唑联合复方玄驹胶囊治疗肥胖性少弱精子症的临床疗效观察[J].生殖医学杂志,2021,4,30(4):509-513. [18] 李海露,王瑞,王卫星,等. 男性性欲与血清生殖激素水平相关性分析[J].中华男科学杂志,2019,25(6):509-513. |